IRS Finalizes Anti-Inversion Regs That Sank $160B Pfizer Deal

By Vidya Kauri · July 11, 2018, 6:49 PM EDT

The Internal Revenue Service implemented regulations Wednesday that a federal court had invalidated last October after they sank a planned $160 billion merger between Pfizer Inc. and Allergan PLC of Ireland....

To view the full article, register now.